Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?

Venkata Yalamanchili, Robert F. Reilly

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Does the risk exceed the benefit for anticoagulation in end-stage renal disease patients with nonrheumatic atrial fibrillation?'. Together they form a unique fingerprint.